# 207

Orphines; new analogs (from 2019-2020) that currently do not produce “hits” on screenings at ER admissions. Resembles the proliferation of Molly & other “date-rape” drugs that see chemists “fiddling” with the graph (description of the elements contained in the molecule that find brain receptors when used knowingly…or unwittingly)

https://www.cfsre.org/nps-discovery/public-alerts/emerging-global-synthetic-opioid-threats-benzimidazol-2-ones-the-orphines

https://axisfortox.com/emerging-substances-the-orphines-class-of-designer-opioids/

Several years ago, British authorities sought to eliminate concert-goer deaths by offering free testing of substances before use…with no consequences to the person submitting the unknown substance for almost immediate screening. We posted that good news immediately after learning of this opportunity. That humanitarian effort was successful in preserving life…until the “designer drugs” hit the streets.

Today, an ER drug screening test may not identify a newly released, tweeked, designer drug. Like a phenomenon that has stayed one or two steps ahead of the DEA and forensic toxicologists for 30 or more years, consequently, they have a slower rate of identifying new substances and disseminating their findings and alerts.